Viatris Inc. (0A5V)
LSE
Closed
Oct 7, 2026
Day's Range
17.4852 wk Range
9.75Overview - 0A5V - Viatris Inc.
Key Statistics
Valuation
Enterprise Value
29.33B
P/E (Trailing)
‪11.39‬
Price / Sales (TTM)
‪1.33‬
Price / Book
‪0.98‬
EV / EBITDA
‪5.72‬
Profitability
Gross Margin
‪38.76%‬
Profit Margin
‪11.88%‬
Operating Margin
‪14.84%‬
Return on Assets
‪2.90%‬
Return on Equity
‪9.12%‬
Ownership
Shares Outstanding
1.15B
Float
1.19B
Held by Insiders
‪0.32%‬
Held by Institutions
‪78.19%‬
Price stats
Beta
‪1.15‬
50-Day Avg
‪16.86‬
200-Day Avg
‪15.19‬
Dividends
Payout Ratio
‪31.37%‬
Frequency
Quarterly
Market Cap - 0A5V - Viatris Inc.
Peers - 0A5V - Viatris Inc.
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on LSE.
- 0A5VLSEViatris Inc.21.13BMarket Cap+32.46%52-week change11.39P/E (Trailing)‪11.88%‬Profit Margin
- HLNLSEHaleon plc2.88TMarket Cap-1.07%52-week change18.76P/E (Trailing)‪14.55%‬Profit Margin
- 0QFPLSEGedeon Richter Plc.1.74TMarket Cap+0.00%52-week change7.34P/E (Trailing)‪19.72%‬Profit Margin
- HIKLSEHikma Pharmaceuticals PLC332.26BMarket Cap-8.04%52-week change12.41P/E (Trailing)‪11.31%‬Profit Margin
- ROSELSERosebank Industries plc308.38BMarket Cap-14.42%52-week change—P/E (Trailing)‪-4.92%‬Profit Margin
- HCMLSEHUTCHMED (China) Limited187.71BMarket Cap-9.26%52-week change108.00P/E (Trailing)‪3.25%‬Profit Margin
- 0MTDLSESwedish Orphan Biovitrum AB158.42BMarket Cap+36.33%52-week change45.80P/E (Trailing)‪15.54%‬Profit Margin
Profile Summary - 0A5V - Viatris Inc.
About
Viatris Inc. is a global healthcare company focused on expanding access to a broad range of medicines across multiple therapeutic areas. Its portfolio includes established prescription brands, generic and complex generic medicines, biosimilars, and over-the-counter consumer products that support treatment and disease…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
